Latest Insights on PING

Great Stuff 6-28-2019 G-20 Weekend: 4 Things You Need to Know June 28, 2019 by Joseph Hargett Great Stuff It’s G-20 weekend! Aren’t you excited? World leaders are gathering in Osaka, Japan, to discuss how best to take advantage of each other and you, the investor. It’s kind of like Family Feud, except on a global scale. For a closer look at this growing kerfuffle, here’s your Friday Four Play: Russian President Vladimir Putin […]
Great Stuff 6-27-2019 Bitcoin’s Crypto Bubble, Thanks to Facebook Libra June 27, 2019 by Joseph Hargett Great Stuff Today, we’re not going to talk about Trump, China or the Democratic debates. You’re welcome. The reason: I’m plumb Xi’ed out. I’ve got no more Trump in the tank, and it’s far too early to worry about what the two million candidates running for the Democratic nomination are debating right now. Besides, bitcoin (CCC: BTC-USD) […]
Big Data companies make billions of dollars of profits every quarter by exploiting data that they’ve taken from us without any compensation. Big Data Regulations Reveal Profits From Your Privacy June 26, 2019 by Ted Bauman Privacy Invasion, Technology, Winning Investor Daily Big Data companies make billions of dollars of profits every quarter by exploiting data that they’ve taken from us without any compensation.
Great Stuff 6-26-2019 Why Now is Not the Time to Buy Micron Stock June 26, 2019 by Joseph Hargett Great Stuff Chips are back, baby! Micron Technology Inc. (Nasdaq: MU) is parting the Red Sea, rallying more than 12% and leading semiconductor stocks to higher ground. Nvidia Corp. (Nasdaq: NVDA) and Advanced Micro Devices Inc. (Nasdaq: AMD) are both up about 5%. Applied Materials Inc. (Nasdaq: AMAT) is up nearly 4%. Even Qualcomm Inc. (Nasdaq: QCOM) […]
Great Stuff 06-25-2019 The Real Question for the $63 Billion AbbVie-Allergan Acquisition June 25, 2019 by Joseph Hargett Great Stuff I know my brain doesn’t work quite right. I wouldn’t be writing Great Stuff if it did. Today, I’m left with a burning question on AbbVie’s $63 billion cash and stock acquisition of Allergan. It’s not about the viability of the combined company. Both AbbVie Inc. (NYSE: ABBV) and Allergan PLC (NYSE: AGN) face serious […]

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

Share This